Effectiveness in clinical practice versus efficacy of dipeptidyl peptidase-4 inhibitors in clinical trials for type 2 diabetes: protocol for systematic review

Study identification

• EU PAS number:
  EUPAS31738
• Study ID:
  32528
• Official title and acronym:
  Effectiveness in clinical practice versus efficacy of dipeptidyl peptidase-4 inhibitors in clinical trials for type 2 diabetes: protocol for systematic review
• DARWIN EU® study:
  No
• Study countries:
  Portugal
• Study status:
  Planned

Research institutions and networks

Institutions

Association for Innovation and Biomedical Research on Light and Image (AIBILI)

Study timelines

Date when funding contract was signed

Planned: 24/06/2019

Actual: 24/06/2019

Study start date

Planned: 31/01/2020

Date of final study report

Planned: 31/12/2019

Sources of funding

Other

More details on funding

AIBILI

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable